Enitociclib (VIP152/formerly BAY1251152) Is a Selective and Active CDK9 Inhibitor : Preliminary Safety and Early Signs of Efficacy in Patients with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Authors :: Mazyar Shadman
Anthony R. Mato
Connie Lee Batlevi
Ian W. Flinn
Martin Gutierrez
Marc Uemura
Don A. Stevens
Daniel Morillo
John C. Byrd
Melanie M. Frigault
George Clemens
Xin Huang
Raquel Izumi
Harvey Wong
Renee Breed
Hermes Garban
Amy J. Johnson
Beatrix Stelte-Ludwig
Arushi Mithal
Joseph Birkett
Ahmed Hamdy
Kerry A. Rogers
Source :: Blood. 140:9454-9456
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools